NVAX Deferred Revenue
Novavax Inc · Deferred Revenue
NVAX Deferred Revenue
Latest reported$140.05Mperiod ending
NVAX FY Deferred Revenue ($0.00 → $140.05M)
Annual deferred revenue
High-resolution chart · PNG
NVAX deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 140,053,000 | |
| 675,067,000 | |
| 241,310,000 | |
| 370,137,000 | |
| 1,422,944,000 | |
| 273,228,000 | |
| 1,678,000 | |
| 10,010,000 | |
| 25,625,000 | |
| 30,079,000 | |
| 34,469,000 | |
| 2,500,000 | |
| 271,000 | |
| 258,000 | |
| 386,000 | |
| 0 | |
| 432,000 | |
| 3,297,000 | |
| 2,980,000 | |
| 0 | |
| 0 | |
| 0 | |
| 250,000 | |
| 275,000 | |
| 1,250,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |